Form 4: CVS Health Executive Steven H. Nelson Acquires 124,378 Stock Options

CVS Health EVP and President of Aetna, Steven H. Nelson, acquired 124,378 stock options on November 30, 2024.

Summary

• Steven H. Nelson, an Executive Vice President and President of Aetna at CVS Health Corp, reported the acquisition of 124,378 stock options.
• The transaction occurred on November 30, 2024, with the options having an exercise price of $71.82.
• These options become exercisable in three equal annual installments, starting November 30, 2025.
• The options expire on November 30, 2031.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation event, which is generally viewed positively as it aligns executive interests with company performance. It is not a major event but is a positive indicator.

Positives

• The acquisition of stock options by a high-ranking executive like Steven H. Nelson can be seen as a positive sign of confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing related to executive compensation, which is common in publicly traded companies. It reflects the company's compensation strategy and aligns executive interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the healthcare industry, similar to practices at companies like UnitedHealth Group (UNH) and Cigna (CI).
• The vesting schedule of three equal annual installments is also a typical practice to incentivize long-term performance.
• The exercise price of $71.82 is specific to CVS Health's stock price at the time of the grant.

Stakeholder Impact

• The stock option grant aligns the executive's interests with those of shareholders, potentially encouraging actions that increase shareholder value.

Key Dates

Keywords

stock options, executive compensation, insider trading, CVS Health, Aetna, Steven H. Nelson